Navigation Links
BioMS Medical announces its intention to renew a normal course issuer bid
Date:9/3/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, Sept. 3 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS) a leading developer in the treatment of multiple sclerosis (MS), announced today that it is renewing its normal course issuer bid. Under the bid, which will be conducted pursuant to the rules of the Toronto Stock Exchange ("TSX"), the Company may purchase up to 1,000,000 of its Class A common shares (the "Common Shares") representing approximately 1.1% of the Company's issued and outstanding Common Shares.

The bid will commence September 8, 2008 and will expire September 7, 2009 or such earlier date as the Company may complete its purchases. The price at which the Company will purchase its shares will be the market price thereof at the time of acquisition. Purchases of Common Shares will be made in the open market through the facilities of the TSX. Any Common Shares acquired by the Company will be cancelled. The Company has 91,180,923 Common Shares issued and outstanding as of August 27, 2008. During the previous 12 months, the Company acquired 343,300 of its Common Shares at an average price of $3.37 per share by way of a normal course issuer bid. The average daily trading volume of the Common Shares on the TSX (exclusive of purchases under the Company's previous normal course issuer bid) for the period February 1, 2008 to July 31, 2008 was 78,945 shares. Daily purchases will be limited to 19,736 Common Shares, other than block purchase exceptions.

The Board of Directors of the Company believes that the market price of the Common Shares may not fully reflect the value of the Company's business and its future business prospects. As a result, the Board has concluded that the purchase and cancellation of the Common Shares may represent an appropriate and desirable use of the Company's funds and provide market stability.

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commer
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...wswire/ -- Dr. Mate Hidvegi, inventor of Avemar fe...lease issued on November 17 by Biropharma Kft, dis...nd self-serving statements about its U.S. competit... from his office in Budapest, Hungary: ,, "The... apply to AveULTRA, www.aveultra.com , is misle...
(Date:11/19/2009)... Mass., Nov. 19 Arlington Medical ...he leading driver of antibiotic selection in nosoc...ty against gram-positive and gram-negative pathoge... nosocomial pneumonia, surveyed European physician...provide appropriate coverage against common pathog...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
(Date:11/18/2009)... Standards and Technology (NIST) has demonstrated ...ing and measuring elusive hazards such as conceale...d or pesticides distributed in soil by wind and ra...nventional techniques for detecting traces of thes...having distinct electrically positive and negative...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Prototype NIST method detects and measures elusive hazards 2
...sides of the planet Uranus, as viewed in this comp...ared wavelengths. Courtesy of Lawrence Sromovsky, ...Capitalizing on the optical capabilities of the K...ented look at the atmosphere of Uranus, providing ...r in the solar system. , ,A pair of images unveile...
...ing slogans or taglines pushing sales are great fo...le and hold them hostage for a second or two. , ,S...re simply confusing, causing them to escape the tr... all the strangely composed slogans promoting vari...ions of dollars. Corporations make extraordinary e...
... like Mick Jagger said: I cant get no satisfaction... to bug you. , ,Old Maslow must have had this in m...strate that getting one set of needs taken care of...s you to start worrying about the next one. This g...s on an iPod. , ,The same applies with the matter ...
Other Biology Technology:UW space scientists use Keck telescope to study wild weather of Uranus 2UW space scientists use Keck telescope to study wild weather of Uranus 3Super advertising slogans, and super costs 2Super advertising slogans, and super costs 3Super advertising slogans, and super costs 4How to solve the salary mystery 2How to solve the salary mystery 3How to solve the salary mystery 4
(Date:11/20/2009)...chers are at work on many scientific and technolog...s recently provided support that totals nearly $4.... investigators under the American Recovery and Rei... been awarded grants for investigation of solar ph...of physics, will enhance the capabilities of NJIT,...
(Date:11/20/2009)...precise measurements of plasma lipoprotein concent...pectroscopy (NMR), researchers led by Daniel Chasm...ical School in Boston, MA, the Framingham Heart St... Stockholm, Sweden and Oxford, England performed g...e among 17,296 women of European ancestry from the...
(Date:11/20/2009)..., DC Nov. 20, 2009) Scientists from the Marine B... of the Naval Research Laboratory (NRL) organized ...ists on an Arctic expedition to initiate methane h...ne the spatial variation of sediment contribution ...oast Guard Cutter Polar Sea as a research platform...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2International expedition investigates climate change, alternative fuels in Arctic 2SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in France 50899 1SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in France 50899 2SpectraScience Secures Distribution for WavSTAT 28R 29 Cancer Diagnosis System in France 50899 3VerteLoc 26amp 3B 238482 3B Tops 500 Surgical Procedures VGI Announces VerteLX 26amp 3B 238482 3B and Seeks Potential Investors for Growth 12915 1VerteLoc 26amp 3B 238482 3B Tops 500 Surgical Procedures VGI Announces VerteLX 26amp 3B 238482 3B and Seeks Potential Investors for Growth 12915 2Connectyx Technologies Holdings Group Inc Increases Revenues by 45 25 and Reduces Expenses by 20 25 for the Second Quarter of 2009 Versus Second Qua 50893 1Connectyx Technologies Holdings Group Inc Increases Revenues by 45 25 and Reduces Expenses by 20 25 for the Second Quarter of 2009 Versus Second Qua 50893 2Connectyx Technologies Holdings Group Inc Increases Revenues by 45 25 and Reduces Expenses by 20 25 for the Second Quarter of 2009 Versus Second Qua 50893 3
...eeding habits, clams have been silent witnesses to... waters. These clams are silent no more, as Dr. R...d her colleagues have reported in their recent pap...Using stable isotope techniques, Carmichael demons...ater inputs to estuaries and coastal food webs by ...
...ersity of New Jersey, has received a four-year, $1...ation to establish the Institute for Food, Nutriti...gers President Richard L. McCormick announced his ...s Annual Address to the University Community on Se...he new institute would focus on obesity and its as...
...emeinschaft (DFG, German Research Foundation) will...ey will be initially funded for the next four year...Among other things, the new Collaborative Research... by viruses and bacteria, scarring of the liver an...e the optimisation of planning, production and uti...
Other Biology News:Rutgers receives US$10 million to establish Institute for Food, Nutrition and Health 2From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 2From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 4From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 5From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 6From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 7
11(R)-HETE from Cayman Chemical
...rotein (PEBP) does not share significant homology ...pressed in the central nervous system, spleen, tes...le PEBP is involved in is exerting inhibitory acti...rombin, neuropsin, and chymotrypsin. Serine prote...
PowerEase 500 Pre-Cast Gel System includes PowerEase Power Supply Temperature Monitoring Probe Xcell SureLock Mini-Cell and Xcell II Blot Module from Invitrogen
Rat Anti-karyopherin alpha2 Monoclonal Antibody, Unconjugated, Clone 2G7 from Santa Cruz Biotechnology, Inc.
Biology Products: